These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

311 related items for PubMed ID: 9187135

  • 1. Expression of MCAM/MUC18 by human melanoma cells leads to increased tumor growth and metastasis.
    Xie S, Luca M, Huang S, Gutman M, Reich R, Johnson JP, Bar-Eli M.
    Cancer Res; 1997 Jun 01; 57(11):2295-303. PubMed ID: 9187135
    [Abstract] [Full Text] [Related]

  • 2. Fully human antibodies to MCAM/MUC18 inhibit tumor growth and metastasis of human melanoma.
    Mills L, Tellez C, Huang S, Baker C, McCarty M, Green L, Gudas JM, Feng X, Bar-Eli M.
    Cancer Res; 2002 Sep 01; 62(17):5106-14. PubMed ID: 12208768
    [Abstract] [Full Text] [Related]

  • 3. Dominant-negative CREB inhibits tumor growth and metastasis of human melanoma cells.
    Xie S, Price JE, Luca M, Jean D, Ronai Z, Bar-Eli M.
    Oncogene; 1997 Oct 23; 15(17):2069-75. PubMed ID: 9366524
    [Abstract] [Full Text] [Related]

  • 4. A fully human antimelanoma cellular adhesion molecule/MUC18 antibody inhibits spontaneous pulmonary metastasis of osteosarcoma cells in vivo.
    McGary EC, Heimberger A, Mills L, Weber K, Thomas GW, Shtivelband M, Lev DC, Bar-Eli M.
    Clin Cancer Res; 2003 Dec 15; 9(17):6560-6. PubMed ID: 14695161
    [Abstract] [Full Text] [Related]

  • 5. MUC18/MCAM (CD146), an activation antigen of human T lymphocytes.
    Pickl WF, Majdic O, Fischer GF, Petzelbauer P, Faé I, Waclavicek M, Stöckl J, Scheinecker C, Vidicki T, Aschauer H, Johnson JP, Knapp W.
    J Immunol; 1997 Mar 01; 158(5):2107-15. PubMed ID: 9036955
    [Abstract] [Full Text] [Related]

  • 6. Molecular mechanisms of melanoma metastasis.
    Bar-Eli M.
    J Cell Physiol; 1997 Nov 01; 173(2):275-8. PubMed ID: 9365536
    [Abstract] [Full Text] [Related]

  • 7. Multiple features of advanced melanoma recapitulated in tumorigenic variants of early stage (radial growth phase) human melanoma cell lines: evidence for a dominant phenotype.
    Bani MR, Rak J, Adachi D, Wiltshire R, Trent JM, Kerbel RS, Ben-David Y.
    Cancer Res; 1996 Jul 01; 56(13):3075-86. PubMed ID: 8674065
    [Abstract] [Full Text] [Related]

  • 8. Enforced expression of MCAM/MUC18 increases in vitro motility and invasiveness and in vivo metastasis of two mouse melanoma K1735 sublines in a syngeneic mouse model.
    Wu GJ, Fu P, Wang SW, Wu MW.
    Mol Cancer Res; 2008 Nov 01; 6(11):1666-77. PubMed ID: 19010815
    [Abstract] [Full Text] [Related]

  • 9. Ectopical expression of human MUC18 increases metastasis of human prostate cancer cells.
    Wu GJ, Peng Q, Fu P, Wang SW, Chiang CF, Dillehay DL, Wu MW.
    Gene; 2004 Mar 03; 327(2):201-13. PubMed ID: 14980717
    [Abstract] [Full Text] [Related]

  • 10. Loss of AP-2 results in up-regulation of MCAM/MUC18 and an increase in tumor growth and metastasis of human melanoma cells.
    Jean D, Gershenwald JE, Huang S, Luca M, Hudson MJ, Tainsky MA, Bar-Eli M.
    J Biol Chem; 1998 Jun 26; 273(26):16501-8. PubMed ID: 9632718
    [Abstract] [Full Text] [Related]

  • 11. Phorbol ester and cyclic AMP-mediated regulation of the melanoma-associated cell adhesion molecule MUC18/MCAM.
    Rummel MM, Sers C, Johnson JP.
    Cancer Res; 1996 May 01; 56(9):2218-23. PubMed ID: 8616875
    [Abstract] [Full Text] [Related]

  • 12. Mel-CAM-specific genetic suppressor elements inhibit melanoma growth and invasion through loss of gap junctional communication.
    Satyamoorthy K, Muyrers J, Meier F, Patel D, Herlyn M.
    Oncogene; 2001 Aug 02; 20(34):4676-84. PubMed ID: 11498790
    [Abstract] [Full Text] [Related]

  • 13. Dominant-negative transcription factor AP-2 augments SB-2 melanoma tumor growth in vivo.
    Gershenwald JE, Sumner W, Calderone T, Wang Z, Huang S, Bar-Eli M.
    Oncogene; 2001 Jun 07; 20(26):3363-75. PubMed ID: 11423987
    [Abstract] [Full Text] [Related]

  • 14. A new Mr 55,000 surface protein implicated in melanoma progression: association with a metastatic phenotype.
    Boukerche H, Baril P, Tabone E, Bérard F, Sanhadji K, Balme B, Wolf F, Perrot H, Thomas L.
    Cancer Res; 2000 Oct 15; 60(20):5848-56. PubMed ID: 11059782
    [Abstract] [Full Text] [Related]

  • 15. Enforced c-KIT expression renders highly metastatic human melanoma cells susceptible to stem cell factor-induced apoptosis and inhibits their tumorigenic and metastatic potential.
    Huang S, Luca M, Gutman M, McConkey DJ, Langley KE, Lyman SD, Bar-Eli M.
    Oncogene; 1996 Dec 05; 13(11):2339-47. PubMed ID: 8957075
    [Abstract] [Full Text] [Related]

  • 16. Integrin beta 3 cDNA transfection into a highly metastatic alpha v beta 3-negative human melanoma cell line inhibits invasion and experimental metastasis.
    Danen EH, van Kraats AA, Cornelissen IM, Ruiter DJ, van Muijen GN.
    Biochem Biophys Res Commun; 1996 Sep 04; 226(1):75-81. PubMed ID: 8806594
    [Abstract] [Full Text] [Related]

  • 17. Melanoma progression-associated glycoprotein MUC18/MCAM mediates homotypic cell adhesion through interaction with a heterophilic ligand.
    Johnson JP, Bar-Eli M, Jansen B, Markhof E.
    Int J Cancer; 1997 Nov 27; 73(5):769-74. PubMed ID: 9398060
    [Abstract] [Full Text] [Related]

  • 18. Functional aspects of three molecules associated with metastasis development in human malignant melanoma.
    Johnson JP, Lehmann JM, Stade BG, Rothbächer U, Sers C, Riethmüller G.
    Invasion Metastasis; 1989 Nov 27; 9(6):338-50. PubMed ID: 2574717
    [Abstract] [Full Text] [Related]

  • 19. MUC18, a melanoma-progression associated molecule, and its potential role in tumor vascularization and hematogenous spread.
    Sers C, Riethmüller G, Johnson JP.
    Cancer Res; 1994 Nov 01; 54(21):5689-94. PubMed ID: 7923217
    [Abstract] [Full Text] [Related]

  • 20. Overexpression of melanoma inhibitory activity (MIA) enhances extravasation and metastasis of A-mel 3 melanoma cells in vivo.
    Guba M, Bosserhoff AK, Steinbauer M, Abels C, Anthuber M, Buettner R, Jauch KW.
    Br J Cancer; 2000 Nov 01; 83(9):1216-22. PubMed ID: 11027436
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.